PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma-Reference-Cited by-同舟云学术

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma

Published:2022-07 Issue:1 Volume:77 Page:163-176
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Wei Chuan-Yuan,Zhu Meng-Xuan,Zhang Peng-Fei,Huang Xiao-Yong,Wan Jin-Kai,Yao Xiu-Zhong,Hu Ze-Tao^ORCID,Chai Xiao-Qiang,Peng Rui,Yang Xuan,Gao Chao,Gao Jian,Wang Si-Wei,Zheng Yi-Min,Tang Zheng,Gao Qiang,Zhou Jian,Fan Jia-Bin,Ke Ai-Wu,Fan Jia

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2021

2. Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma;Dang;Cancer Cell,2017

3. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

4. Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial;Finn;J Clin Oncol,2020

5. The evolving treatment paradigm of advanced hepatocellular carcinoma: putting all the pieces back together;D'Alessio;Curr Opin Oncol,2021

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

2. Hepatic arterial-infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma;2024-09-09

3. Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinoma;Heliyon;2024-09

4. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy;Frontiers in Immunology;2024-08-07

5. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside;Experimental Hematology & Oncology;2024-08-01